APO Research
Talk to an analyst

APO RESEARCH · REPORT

Advanced Therapy Medicinal Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Advanced Therapy Medicinal Products Market Analysis and Forecast 2026-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchAdvanced Therapy Medicinal Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Advanced Therapy Medicinal Products Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Advanced Therapy Medicinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advanced Therapy Medicinal Products Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Advanced Therapy Medicinal Products Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Advanced Therapy Medicinal Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Advanced Therapy Medicinal Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Advanced Therapy Medicinal Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Advanced Therapy Medicinal Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Advanced Therapy Medicinal Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Advanced Therapy Medicinal Products include Novartis, Vericel Corporation, UniQure, Spark Therapeutics, PHARMICELL, MEDIPOST, Kolon TissueGene, JCR Pharmaceuticals and Gilead Lifesciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Advanced Therapy Medicinal Products, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Advanced Therapy Medicinal Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Advanced Therapy Medicinal Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Advanced Therapy Medicinal Products revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Advanced Therapy Medicinal Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Advanced Therapy Medicinal Products revenue, projected growth trends, production technology, application and end-user industry.

Advanced Therapy Medicinal Products Segment by Company

Novartis

Vericel Corporation

UniQure

Spark Therapeutics

PHARMICELL

MEDIPOST

Kolon TissueGene

JCR Pharmaceuticals

Gilead Lifesciences

Celgene Corporation

Bluebird Bio

Advanced Therapy Medicinal Products Segment by Type

Tissue Engineered Product

Cell Therapy

Gene Therapy

CAR-T Therapy

Advanced Therapy Medicinal Products Segment by Application

Hospital

Clinic

Advanced Therapy Medicinal Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapy Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapy Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapy Medicinal Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Advanced Therapy Medicinal Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Advanced Therapy Medicinal Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Advanced Therapy Medicinal Products revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Advanced Therapy Medicinal Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tissue Engineered Product Major Player Table 3. Cell Therapy Major Player Table 4. Gene Therapy Major Player Table 5. CAR-T Therapy Major Player Table 6. Global Advanced Therapy Medicinal Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Advanced Therapy Medicinal Products Industry Trends Table 10. Advanced Therapy Medicinal Products Industry Drivers Table 11. Advanced Therapy Medicinal Products Industry Opportunities and Challenges Table 12. Advanced Therapy Medicinal Products Industry Restraints Table 13. Global Advanced Therapy Medicinal Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Advanced Therapy Medicinal Products Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Advanced Therapy Medicinal Products Market Share by Region (2021-2026) Table 16. Global Advanced Therapy Medicinal Products Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Advanced Therapy Medicinal Products Market Share by Region (2027-2032) Table 18. Global Advanced Therapy Medicinal Products Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Advanced Therapy Medicinal Products Revenue Market Share by Players (2021-2026) Table 20. Global Advanced Therapy Medicinal Products Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Advanced Therapy Medicinal Products Key Players Headquarters & Area Served Table 22. Global Advanced Therapy Medicinal Products Players, Product Type & Application Table 23. Global Advanced Therapy Medicinal Products Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Advanced Therapy Medicinal Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Advanced Therapy Medicinal Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Advanced Therapy Medicinal Products Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Advanced Therapy Medicinal Products Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Advanced Therapy Medicinal Products Revenue Market Share by Type (2021-2026) Table 30. Global Advanced Therapy Medicinal Products Revenue Market Share by Type (2027-2032) Table 31. Global Advanced Therapy Medicinal Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Advanced Therapy Medicinal Products Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Advanced Therapy Medicinal Products Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2021-2026) Table 35. Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2027-2032) Table 36. Novartis Company Information Table 37. Novartis Business Overview Table 38. Novartis Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis Advanced Therapy Medicinal Products Product Portfolio Table 40. Novartis Recent Development Table 41. Vericel Corporation Company Information Table 42. Vericel Corporation Business Overview Table 43. Vericel Corporation Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Vericel Corporation Advanced Therapy Medicinal Products Product Portfolio Table 45. Vericel Corporation Recent Development Table 46. UniQure Company Information Table 47. UniQure Business Overview Table 48. UniQure Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. UniQure Advanced Therapy Medicinal Products Product Portfolio Table 50. UniQure Recent Development Table 51. Spark Therapeutics Company Information Table 52. Spark Therapeutics Business Overview Table 53. Spark Therapeutics Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Spark Therapeutics Advanced Therapy Medicinal Products Product Portfolio Table 55. Spark Therapeutics Recent Development Table 56. PHARMICELL Company Information Table 57. PHARMICELL Business Overview Table 58. PHARMICELL Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. PHARMICELL Advanced Therapy Medicinal Products Product Portfolio Table 60. PHARMICELL Recent Development Table 61. MEDIPOST Company Information Table 62. MEDIPOST Business Overview Table 63. MEDIPOST Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. MEDIPOST Advanced Therapy Medicinal Products Product Portfolio Table 65. MEDIPOST Recent Development Table 66. Kolon TissueGene Company Information Table 67. Kolon TissueGene Business Overview Table 68. Kolon TissueGene Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Kolon TissueGene Advanced Therapy Medicinal Products Product Portfolio Table 70. Kolon TissueGene Recent Development Table 71. JCR Pharmaceuticals Company Information Table 72. JCR Pharmaceuticals Business Overview Table 73. JCR Pharmaceuticals Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Portfolio Table 75. JCR Pharmaceuticals Recent Development Table 76. Gilead Lifesciences Company Information Table 77. Gilead Lifesciences Business Overview Table 78. Gilead Lifesciences Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Gilead Lifesciences Advanced Therapy Medicinal Products Product Portfolio Table 80. Gilead Lifesciences Recent Development Table 81. Celgene Corporation Company Information Table 82. Celgene Corporation Business Overview Table 83. Celgene Corporation Advanced Therapy Medicinal Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Celgene Corporation Advanced Therapy Medicinal Products Product Portfolio Table 85. Celgene Corporation Recent Development Table 86. Bluebird Bio Company Information Table 87. Bluebird Bio Business Overview Table 88. Bluebird Bio Advanced Therapy Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bluebird Bio Advanced Therapy Medicinal Products Product Portfolio Table 90. Bluebird Bio Recent Development Table 91. North America Advanced Therapy Medicinal Products Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Advanced Therapy Medicinal Products Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Advanced Therapy Medicinal Products Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Advanced Therapy Medicinal Products Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Advanced Therapy Medicinal Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Advanced Therapy Medicinal Products Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Advanced Therapy Medicinal Products Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Advanced Therapy Medicinal Products Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Advanced Therapy Medicinal Products Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Advanced Therapy Medicinal Products Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Advanced Therapy Medicinal Products Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Advanced Therapy Medicinal Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Advanced Therapy Medicinal Products Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Advanced Therapy Medicinal Products Revenue by Country (US$ Million) & (2027-2032) Table 105. China Advanced Therapy Medicinal Products Revenue by Type (2021-2026) & (US$ Million) Table 106. China Advanced Therapy Medicinal Products Revenue by Type (2027-2032) & (US$ Million) Table 107. China Advanced Therapy Medicinal Products Revenue by Application (2021-2026) & (US$ Million) Table 108. China Advanced Therapy Medicinal Products Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Advanced Therapy Medicinal Products Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Advanced Therapy Medicinal Products Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Advanced Therapy Medicinal Products Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Advanced Therapy Medicinal Products Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Advanced Therapy Medicinal Products Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Advanced Therapy Medicinal Products Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Advanced Therapy Medicinal Products Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Advanced Therapy Medicinal Products Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Advanced Therapy Medicinal Products Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Advanced Therapy Medicinal Products Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Advanced Therapy Medicinal Products Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Advanced Therapy Medicinal Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Advanced Therapy Medicinal Products Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Advanced Therapy Medicinal Products Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Advanced Therapy Medicinal Products Image Figure 2. Global Advanced Therapy Medicinal Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advanced Therapy Medicinal Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tissue Engineered Product Image Figure 5. Cell Therapy Image Figure 6. Gene Therapy Image Figure 7. CAR-T Therapy Image Figure 8. Global Advanced Therapy Medicinal Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Advanced Therapy Medicinal Products Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Advanced Therapy Medicinal Products Market Size (US$ Million) & (2021-2032) Figure 13. Global Advanced Therapy Medicinal Products Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Advanced Therapy Medicinal Products Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Advanced Therapy Medicinal Products Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Advanced Therapy Medicinal Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Advanced Therapy Medicinal Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Advanced Therapy Medicinal Products Revenue Market Share by Type (2021-2032) Figure 20. Global Advanced Therapy Medicinal Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2021-2032) Figure 23. North America Advanced Therapy Medicinal Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032) Figure 25. North America Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032) Figure 26. North America Advanced Therapy Medicinal Products Revenue Share by Country (2021-2032) Figure 27. United States Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Advanced Therapy Medicinal Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032) Figure 32. Europe Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032) Figure 33. Europe Advanced Therapy Medicinal Products Revenue Share by Country (2021-2032) Figure 34. Germany Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Advanced Therapy Medicinal Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032) Figure 44. China Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032) Figure 45. Asia Advanced Therapy Medicinal Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032) Figure 47. Asia Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032) Figure 48. Asia Advanced Therapy Medicinal Products Revenue Share by Region (2021-2032) Figure 49. Japan Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Advanced Therapy Medicinal Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032) Figure 57. SAMEA Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032) Figure 58. SAMEA Advanced Therapy Medicinal Products Revenue Share by Country (2021-2032) Figure 59. Brazil Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Advanced Therapy Medicinal Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue Engineered Product
  • Cell Therapy
  • Gene Therapy
  • CAR-T Therapy
Applications
  • Hospital
  • Clinic
Companies covered
  • Novartis
  • Vericel Corporation
  • UniQure
  • Spark Therapeutics
  • PHARMICELL
  • MEDIPOST
  • Kolon TissueGene
  • JCR Pharmaceuticals
  • Gilead Lifesciences
  • Celgene Corporation
  • Bluebird Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Advanced Therapy Medicinal Products Market by Type
  3. 1.2.1 Global Advanced Therapy Medicinal Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tissue Engineered Product
  5. 1.2.3 Cell Therapy
  6. 1.2.4 Gene Therapy
  7. 1.2.5 CAR-T Therapy
  8. 1.3 Advanced Therapy Medicinal Products Market by Application
  9. 1.3.1 Global Advanced Therapy Medicinal Products Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Advanced Therapy Medicinal Products Market Dynamics
  1. 2.1 Advanced Therapy Medicinal Products Industry Trends
  2. 2.2 Advanced Therapy Medicinal Products Industry Drivers
  3. 2.3 Advanced Therapy Medicinal Products Industry Opportunities and Challenges
  4. 2.4 Advanced Therapy Medicinal Products Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Advanced Therapy Medicinal Products Market Perspective (2021-2032)
  2. 3.2 Global Advanced Therapy Medicinal Products Growth Trends by Region
  3. 3.2.1 Global Advanced Therapy Medicinal Products Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Advanced Therapy Medicinal Products Market Size by Region (2021-2026)
  5. 3.2.3 Global Advanced Therapy Medicinal Products Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Advanced Therapy Medicinal Products Revenue by Players
  2. 4.1.1 Global Advanced Therapy Medicinal Products Revenue by Players (2021-2026)
  3. 4.1.2 Global Advanced Therapy Medicinal Products Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Advanced Therapy Medicinal Products Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Advanced Therapy Medicinal Products Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Advanced Therapy Medicinal Products Key Players Headquarters & Area Served
  7. 4.4 Global Advanced Therapy Medicinal Products Players, Product Type & Application
  8. 4.5 Global Advanced Therapy Medicinal Products Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Advanced Therapy Medicinal Products Market CR5 and HHI
  11. 4.6.3 2025 Advanced Therapy Medicinal Products Tier 1, Tier 2, and Tier 3
5 Advanced Therapy Medicinal Products Market Size by Type
  1. 5.1 Global Advanced Therapy Medicinal Products Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Advanced Therapy Medicinal Products Revenue by Type (2021-2032)
  3. 5.3 Global Advanced Therapy Medicinal Products Revenue Market Share by Type (2021-2032)
6 Advanced Therapy Medicinal Products Market Size by Application
  1. 6.1 Global Advanced Therapy Medicinal Products Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Advanced Therapy Medicinal Products Revenue by Application (2021-2032)
  3. 6.3 Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Advanced Therapy Medicinal Products Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Vericel Corporation
  8. 7.2.1 Vericel Corporation Company Information
  9. 7.2.2 Vericel Corporation Business Overview
  10. 7.2.3 Vericel Corporation Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Vericel Corporation Advanced Therapy Medicinal Products Product Portfolio
  12. 7.2.5 Vericel Corporation Recent Developments
  13. 7.3 UniQure
  14. 7.3.1 UniQure Company Information
  15. 7.3.2 UniQure Business Overview
  16. 7.3.3 UniQure Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  17. 7.3.4 UniQure Advanced Therapy Medicinal Products Product Portfolio
  18. 7.3.5 UniQure Recent Developments
  19. 7.4 Spark Therapeutics
  20. 7.4.1 Spark Therapeutics Company Information
  21. 7.4.2 Spark Therapeutics Business Overview
  22. 7.4.3 Spark Therapeutics Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Spark Therapeutics Advanced Therapy Medicinal Products Product Portfolio
  24. 7.4.5 Spark Therapeutics Recent Developments
  25. 7.5 PHARMICELL
  26. 7.5.1 PHARMICELL Company Information
  27. 7.5.2 PHARMICELL Business Overview
  28. 7.5.3 PHARMICELL Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PHARMICELL Advanced Therapy Medicinal Products Product Portfolio
  30. 7.5.5 PHARMICELL Recent Developments
  31. 7.6 MEDIPOST
  32. 7.6.1 MEDIPOST Company Information
  33. 7.6.2 MEDIPOST Business Overview
  34. 7.6.3 MEDIPOST Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  35. 7.6.4 MEDIPOST Advanced Therapy Medicinal Products Product Portfolio
  36. 7.6.5 MEDIPOST Recent Developments
  37. 7.7 Kolon TissueGene
  38. 7.7.1 Kolon TissueGene Company Information
  39. 7.7.2 Kolon TissueGene Business Overview
  40. 7.7.3 Kolon TissueGene Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Kolon TissueGene Advanced Therapy Medicinal Products Product Portfolio
  42. 7.7.5 Kolon TissueGene Recent Developments
  43. 7.8 JCR Pharmaceuticals
  44. 7.8.1 JCR Pharmaceuticals Company Information
  45. 7.8.2 JCR Pharmaceuticals Business Overview
  46. 7.8.3 JCR Pharmaceuticals Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  47. 7.8.4 JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Portfolio
  48. 7.8.5 JCR Pharmaceuticals Recent Developments
  49. 7.9 Gilead Lifesciences
  50. 7.9.1 Gilead Lifesciences Company Information
  51. 7.9.2 Gilead Lifesciences Business Overview
  52. 7.9.3 Gilead Lifesciences Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Gilead Lifesciences Advanced Therapy Medicinal Products Product Portfolio
  54. 7.9.5 Gilead Lifesciences Recent Developments
  55. 7.10 Celgene Corporation
  56. 7.10.1 Celgene Corporation Company Information
  57. 7.10.2 Celgene Corporation Business Overview
  58. 7.10.3 Celgene Corporation Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Celgene Corporation Advanced Therapy Medicinal Products Product Portfolio
  60. 7.10.5 Celgene Corporation Recent Developments
  61. 7.11 Bluebird Bio
  62. 7.11.1 Bluebird Bio Company Information
  63. 7.11.2 Bluebird Bio Business Overview
  64. 7.11.3 Bluebird Bio Advanced Therapy Medicinal Products Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bluebird Bio Advanced Therapy Medicinal Products Product Portfolio
  66. 7.11.5 Bluebird Bio Recent Developments
8 North America
  1. 8.1 North America Advanced Therapy Medicinal Products Revenue (2021-2032)
  2. 8.2 North America Advanced Therapy Medicinal Products Revenue by Type (2021-2032)
  3. 8.2.1 North America Advanced Therapy Medicinal Products Revenue by Type (2021-2026)
  4. 8.2.2 North America Advanced Therapy Medicinal Products Revenue by Type (2027-2032)
  5. 8.3 North America Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032)
  6. 8.4 North America Advanced Therapy Medicinal Products Revenue by Application (2021-2032)
  7. 8.4.1 North America Advanced Therapy Medicinal Products Revenue by Application (2021-2026)
  8. 8.4.2 North America Advanced Therapy Medicinal Products Revenue by Application (2027-2032)
  9. 8.5 North America Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032)
  10. 8.6 North America Advanced Therapy Medicinal Products Revenue by Country
  11. 8.6.1 North America Advanced Therapy Medicinal Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Advanced Therapy Medicinal Products Revenue by Country (2021-2026)
  13. 8.6.3 North America Advanced Therapy Medicinal Products Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Advanced Therapy Medicinal Products Revenue (2021-2032)
  2. 9.2 Europe Advanced Therapy Medicinal Products Revenue by Type (2021-2032)
  3. 9.2.1 Europe Advanced Therapy Medicinal Products Revenue by Type (2021-2026)
  4. 9.2.2 Europe Advanced Therapy Medicinal Products Revenue by Type (2027-2032)
  5. 9.3 Europe Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032)
  6. 9.4 Europe Advanced Therapy Medicinal Products Revenue by Application (2021-2032)
  7. 9.4.1 Europe Advanced Therapy Medicinal Products Revenue by Application (2021-2026)
  8. 9.4.2 Europe Advanced Therapy Medicinal Products Revenue by Application (2027-2032)
  9. 9.5 Europe Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032)
  10. 9.6 Europe Advanced Therapy Medicinal Products Revenue by Country
  11. 9.6.1 Europe Advanced Therapy Medicinal Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Advanced Therapy Medicinal Products Revenue by Country (2021-2026)
  13. 9.6.3 Europe Advanced Therapy Medicinal Products Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Advanced Therapy Medicinal Products Revenue (2021-2032)
  2. 10.2 China Advanced Therapy Medicinal Products Revenue by Type (2021-2032)
  3. 10.2.1 China Advanced Therapy Medicinal Products Revenue by Type (2021-2026)
  4. 10.2.2 China Advanced Therapy Medicinal Products Revenue by Type (2027-2032)
  5. 10.3 China Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032)
  6. 10.4 China Advanced Therapy Medicinal Products Revenue by Application (2021-2032)
  7. 10.4.1 China Advanced Therapy Medicinal Products Revenue by Application (2021-2026)
  8. 10.4.2 China Advanced Therapy Medicinal Products Revenue by Application (2027-2032)
  9. 10.5 China Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Advanced Therapy Medicinal Products Revenue (2021-2032)
  2. 11.2 Asia Advanced Therapy Medicinal Products Revenue by Type (2021-2032)
  3. 11.2.1 Asia Advanced Therapy Medicinal Products Revenue by Type (2021-2026)
  4. 11.2.2 Asia Advanced Therapy Medicinal Products Revenue by Type (2027-2032)
  5. 11.3 Asia Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032)
  6. 11.4 Asia Advanced Therapy Medicinal Products Revenue by Application (2021-2032)
  7. 11.4.1 Asia Advanced Therapy Medicinal Products Revenue by Application (2021-2026)
  8. 11.4.2 Asia Advanced Therapy Medicinal Products Revenue by Application (2027-2032)
  9. 11.5 Asia Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032)
  10. 11.6 Asia Advanced Therapy Medicinal Products Revenue by Country
  11. 11.6.1 Asia Advanced Therapy Medicinal Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Advanced Therapy Medicinal Products Revenue by Country (2021-2026)
  13. 11.6.3 Asia Advanced Therapy Medicinal Products Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Advanced Therapy Medicinal Products Revenue (2021-2032)
  2. 12.2 SAMEA Advanced Therapy Medicinal Products Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Advanced Therapy Medicinal Products Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Advanced Therapy Medicinal Products Revenue by Type (2027-2032)
  5. 12.3 SAMEA Advanced Therapy Medicinal Products Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Advanced Therapy Medicinal Products Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Advanced Therapy Medicinal Products Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Advanced Therapy Medicinal Products Revenue by Application (2027-2032)
  9. 12.5 SAMEA Advanced Therapy Medicinal Products Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Advanced Therapy Medicinal Products Revenue by Country
  11. 12.6.1 SAMEA Advanced Therapy Medicinal Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Advanced Therapy Medicinal Products Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Advanced Therapy Medicinal Products Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst